SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-054427
Filing Date
2020-04-30
Accepted
2020-04-30 16:07:37
Documents
47
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2014614d1_10q.htm 10-Q 230305
2 EXHIBIT 31.1 tm2014614d1_ex31-1.htm EX-31.1 10823
3 EXHIBIT 31.2 tm2014614d1_ex31-2.htm EX-31.2 10996
4 EXHIBIT 32.1 tm2014614d1_ex32-1.htm EX-32.1 5108
5 EXHIBIT 32.2 tm2014614d1_ex32-2.htm EX-32.2 5407
  Complete submission text file 0001104659-20-054427.txt   1419822

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT enzn-20200331.xml EX-101.INS 188821
7 XBRL TAXONOMY EXTENSION SCHEMA enzn-20200331.xsd EX-101.SCH 23164
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enzn-20200331_cal.xml EX-101.CAL 14045
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enzn-20200331_def.xml EX-101.DEF 31729
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE enzn-20200331_lab.xml EX-101.LAB 137046
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enzn-20200331_pre.xml EX-101.PRE 114541
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36435 | Film No.: 20835688
SIC: 2836 Biological Products, (No Diagnostic Substances)